No Data
Zeria Pharmaceutical Reports Strong Mid-Year Growth
Zeria Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)
Toyota, Itochu, NYK Line, Nitori Holdings (6th)
※The above calendar is only a schedule and may be subject to change depending on the company's circumstances.---------------------------------------November 6th (Wed) <1301> Kyokuyo <1332> Nissui <1420> Sanyo H <165A> SBI Leos <1799> Daiichi Construction <1814> Oomatsu Ken <1884> Nichi Doro <1898> Seiki Tokyu <196
Zeria Pharmaceutical: Notice regarding revisions to earnings forecasts
Line Yahoo, Mitsubishi Heavy, nintendo co ltd, Kawasaki ship (5th)
※The above calendar is just a schedule and may be subject to change depending on the company's convenience.---------------------------------------November 5th (Tuesday)＜1723＞Nihondenki＜1787＞Nakabotech＜1826＞Satakensha＜1945＞Tokyo Enesis＜1967＞Yamato＜2222＞Kotobuki Spirits＜2281＞Prima Ham＜2372＞Ayro inc
Zeria Pharmaceutical To Go Ex-Dividend On September 27th, 2024 With 23 JPY Dividend Per Share
September 26th (Japan Standard Time) - $Zeria Pharmaceutical(4559.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 23 JPY dividend per
No Data
No Data